Keywords: gilead, preveon, expanded, access, under, expanded-access, program
Gilead's Preveon, Expanded Access
Article | 11 December 1997
Under an expanded-access program, Gilead Sciences is to donate itsexperimental AIDS vaccine, Preveon (adefovir dipivoxil), to HIV-positive patients aged over 13 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
